AI 기반 임상시험 솔루션 프로바이더 시장 규모는 향후 수년간 비약적인 성장이 예상될 예정입니다. 예측 기간의 성장은 실제 증거(REW)와의 통합, 자연어 처리(NPL)의 발전, 분산형 임상시험 채택, 치료 영역의 확장, 향상된 예측 분석에 기인할 수 있습니다. 예측 기간의 주요 동향으로는 바이오 테크놀로지 기업이나 제약 기업과의 제휴, 환자 중심의 어프로치, 시험 설계를 위한 예측 분석, 리얼 월드 에비던스와의 통합, 데이터 보안을 위한 블록 체인 등을 들 수 있습니다.
AI 기술의 채용 확대가 향후 AI 기반 임상시험 솔루션 프로바이더 시장의 확대를 견인할 것으로 예측됩니다. AI 기반 임상시험 솔루션 프로바이더는 임상시험 프로세스의 다양한 단계를 통해 효율성, 정확성, 혁신성을 높이고 환자 결과 개선 및 의학 연구의 진보를 이끌어내기 위해 AI 기술을 활용하는 경우가 늘어나고 있습니다. 예를 들어, 2022년 5월 미국의 기술 기업인 IBM(International Business Machines Corporation)은 전 세계적으로 AI 도입률이 전년 대비 35% 증가하여 크게 증가했다고 보고했습니다. 또한 약 35%의 조직이 사내에 AI를 도입했다고 답했으며, 42%는 도입을 고려 중이고, 3분의 2(66%)는 지속 가능성 목표를 달성하기 위해 현재 AI를 구현 중이거나 활용할 계획이라고 답했습니다.
AI 기반 임상시험 솔루션 프로바이더 시장의 주요 기업은 임상 개발을 가속화하고 시장에서의 지위를 강화하기 위해 Saama AI 주도형 데이터 플랫폼과 같은 혁신적인 기술 솔루션을 적극적으로 개발하고 있습니다. AI 주도형 데이터 플랫폼은 인공지능(AI)과 머신러닝(ML)을 활용하여 다양한 데이터 관리 및 분석 프로세스를 자동화 및 강화합니다. 예를 들어, 2023년 6월 미국 소프트웨어 회사인 Saama Technologies, Inc.는 Saama AI-driven data platform을 발표했습니다. 이 플랫폼은 데이터를 중앙 집중화 및 표준화하여 임상시험 프로세스를 최적화하고 시험 업무, 재무 및 환자 데이터에 대한 실시간 인사이트를 제공합니다. AI와 고급 분석을 채택함으로써 이 플랫폼은 작업을 자동화하고 생산성을 높이고 환자 행동에 대한 깊은 인사이트를 제공합니다. Saama는 데이터 허브, 운영 인사이트, 환자 인사이트, S2S, SDQ와 같은 SaaS 솔루션을 통해 AI 기반 임상시험 솔루션 프로바이더가 효율성, 정확성 및 효율성을 극대화하고 수작업과 자원 집약적인 작업을 줄여 임상시험을 간소화할 수 있도록 지원합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 AI 기반 임상시험 솔루션 프로바이더 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
- 최종 이용 산업의 분석
- 세계의 AI 기반 임상시험 솔루션 프로바이더 시장 : 성장률 분석
- 세계의 AI 기반 임상시험 솔루션 프로바이더 시장 실적 : 규모와 성장(2019-2024년)
- 세계의 AI 기반 임상시험 솔루션 프로바이더 시장 예측 : 규모와 성장(2024-2029년, 2034년)
- 세계의 AI 기반 임상시험 솔루션 프로바이더 전체 시장(TAM)
제6장 시장 세분화
- 세계의 AI 기반 임상시험 솔루션 프로바이더 시장 : 임상시험 단계별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- Phase-I
- Phase-II
- Phase-III
- 세계의 AI 기반 임상시험 솔루션 프로바이더 시장 : 치료 용도별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 종양학
- 심혈관 질환
- 신경계 질환 또는 상태
- 대사 질환
- 감염성 질환
- 기타 치료 용도
- 세계의 AI 기반 임상시험 솔루션 프로바이더 시장 : 최종 사용자별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 제약회사
- 학계
- 기타 최종 사용자
- 세계의 AI 기반 임상시험 솔루션 프로바이더 시장 : Phase-I 유형별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 안전성 및 용량 연구
- 초기 약물동력학 연구
- 세계의 AI 기반 임상시험 솔루션 프로바이더 시장 : Phase-II 유형별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 효능 연구
- 용량-반응 연구
- 세계의 AI 기반 임상시험 솔루션 프로바이더 시장 : Phase-III 유형별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 확인 연구
- 비교 효과 연구
제7장 지역별/국가별 분석
- 세계의 AI 기반 임상시험 솔루션 프로바이더 시장 : 지역별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 AI 기반 임상시험 솔루션 프로바이더 시장 : 국가별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- AI 기반 임상시험 솔루션 프로바이더 시장 : 경쟁 구도
- AI 기반 임상시험 솔루션 프로바이더 시장 : 기업 프로파일
- International Business Machines Corporation 개요, 제품 및 서비스, 전략 및 재무 분석
- AstraZeneca 개요, 제품 및 서비스, 전략 및 재무 분석
- Takeda Pharmaceutical Company Limited 개요, 제품 및 서비스, 전략 및 재무 분석
- IQVIA Holdings Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- BenevolentAI SA 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Charles River Laboratories
- Flatiron Health
- Saama Technologies Inc.
- CytoReason
- Median Technologies SAS
- Concentro Health AI.
- AiCure, LLC
- DEEP LENS AI Inc.
- GNS Healthcare, Inc.
- Ardigen
- Koneksa Health Inc.
- Unlearn.AI Inc.
- PathAI Inc.
- Deep 6 AI Inc.
- Intelligencia Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- AI 기반 임상시험 솔루션 프로바이더 시장(2029년) : 새로운 기회를 제공하는 국가
- AI 기반 임상시험 솔루션 프로바이더 시장(2029년) : 새로운 기회를 제공하는 부문
- AI 기반 임상시험 솔루션 프로바이더 시장(2029년) : 성장 전략
제36장 부록
KTH
AI-based clinical trial solution providers are entities that offer technological solutions utilizing artificial intelligence (AI) for different facets of the clinical trial process in the healthcare and pharmaceutical sectors. These solutions aim to improve the efficiency, accuracy, and overall effectiveness of clinical trials, ranging from study design and patient recruitment to data analysis and regulatory compliance.
The main types of clinical trial phases addressed by AI-based clinical trial solution providers include phase I, phase II, and phase III. Phase I represents the initial stage of clinical trials conducted during the development of a new medical intervention, such as a drug, vaccine, or medical device. These solutions cater to various therapeutic applications, including oncology, cardiovascular diseases, neurological conditions, metabolic disorders, infectious diseases, and others. They are utilized by end-users such as pharmaceutical companies, academia, and other stakeholders involved in clinical research.
The AI-based clinical trial solution providers market research report is one of a series of new reports from The Business Research Company that provides AI-based clinical trial solution providers market statistics, including AI-based clinical trial solution providers industry global market size, regional shares, competitors with a AI-based clinical trial solution providers market share, detailed AI-based clinical trial solution providers market segments, market trends and opportunities, and any further data you may need to thrive in the AI-based clinical trial solution providers industry. This AI-based clinical trial solution providers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The AI-based clinical trial solution providers market size has grown exponentially in recent years. It will grow from $2.47 billion in 2024 to $3.04 billion in 2025 at a compound annual growth rate (CAGR) of 23.1%. The growth in the historic period can be attributed to increasing complexity in clinical trials, growing volume of clinical trial data, regulatory compliance challenges, drug discovery and development demands, personalized medicine trends.
The AI-based clinical trial solution providers market size is expected to see exponential growth in the next few years. It will grow to $6.96 billion in 2029 at a compound annual growth rate (CAGR) of 23.0%. The growth in the forecast period can be attributed to integration with real-world evidence (REW), advancements in natural language processing (NPL), decentralized clinical trials adoption, expansion of therapeutic areas, enhanced predictive analytics. Major trends in the forecast period include collaboration with biotech and pharma companies, patient-centric approaches, predictive analytics for trial design, real-world evidence integration, blockchain for data security.
The growing adoption of AI technology is anticipated to drive the expansion of the market for AI-based clinical trial solution providers in the future. AI, or artificial intelligence, involves the development of computer systems or software capable of performing tasks typically requiring human intelligence. Clinical trial solution providers are increasingly leveraging AI technology to enhance efficiency, accuracy, and innovation throughout various stages of the clinical trial process, leading to improved patient outcomes and advancements in medical research. For example, in May 2022, The International Business Machines Corporation (IBM), a US-based technology corporation, reported a significant global increase in the adoption rate of AI, with a 35% rise compared to the previous year. Moreover, around 35% of organizations reported adopting AI in their company, while 42% are considering its adoption, and two-thirds (66%) are either currently implementing or planning to utilize AI to achieve their sustainability goals. Consequently, the rising adoption of AI technology is fueling the growth of the AI-based clinical trial solution provider market.
Leading companies in the AI-based clinical trial solution providers market are actively developing innovative technological solutions, such as the Saama AI-driven data platform, to expedite clinical development and reinforce their market position. An AI-driven data platform utilizes artificial intelligence (AI) and machine learning (ML) to automate and enhance various data management and analysis processes. For instance, in June 2023, Saama Technologies, Inc., a US-based software company, unveiled the Saama AI-driven data platform. This platform optimizes clinical trial processes by centralizing and standardizing data, providing real-time insights into trial operations, financials, and patient data. By employing AI and advanced analytics, the platform automates tasks, boosts productivity, and delivers profound insights into patient behaviors. Through SaaS solutions such as data hubs, operational insights, patient insights, S2S, and SDQ, Saama empowers AI-based clinical trial solution providers to maximize efficiency, accuracy, and effectiveness while reducing manual, resource-intensive activities to streamline clinical trials.
In September 2023, Florence Healthcare, a US-based healthcare company, acquired VersaTrial Inc. for an undisclosed sum. This acquisition brings together two pioneering entities in the eClinical space, combining their complementary strengths to deliver a more robust solution for research sites, CROs, and sponsors. VersaTrial Inc. is a US-based provider of AI-based clinical trial solutions.
Major companies operating in the AI-based clinical trial solution providers market report are International Business Machines Corporation, AstraZeneca, Takeda Pharmaceutical Company Limited, IQVIA Holdings Inc., BenevolentAI SA, Charles River Laboratories, Flatiron Health, Saama Technologies Inc., CytoReason, Median Technologies SAS, Concentro Health AI., AiCure, LLC, DEEP LENS AI Inc., GNS Healthcare, Inc., Ardigen, Koneksa Health Inc., Unlearn.AI Inc., PathAI Inc., Deep 6 AI Inc., Intelligencia Inc., Exscientia, Prometheus Biosciences, Inc., Renalytix AI PLC, BioAge Labs Inc., Mendel Health Inc
North America was the largest region in the AI-based clinical trial solution providers market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ai-based clinical trial solution providers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the AI-based clinical trial solution provider market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The AI-based clinical trial solution provider market consists of revenues earned by entities by providing services such as data analysis, patient recruitment and retention, drug trial process optimization, and predictive analytics for clinical outcomes. The AI-based clinical trial solution providers market also includes sales of mobile devices, medical devices and servers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
AI-Based Clinical Trial Solution Providers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on ai-based clinical trial solution providers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for ai-based clinical trial solution providers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ai-based clinical trial solution providers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Clinical Trial Phase: Phase-I; Phase-Ii; Phase-Iii
- 2) By Therapeutic Application: Oncology; Cardiovascular Diseases; Neurological Diseases Or Conditions Metabolic Diseases; Infectious Diseases; Other Therapeutic Applications
- 3) By End-User: Pharmaceutical Companies; Academia; Other End-Users
- Subsegments:
- 1) By Phase-I: Safety And Dosage Studies; Early Pharmacokinetics Studies
- 2) By Phase-Ii: Efficacy Studies; Dose-Response Studies
- 3) By Phase-Iii: Confirmatory Studies; Comparative Effectiveness Research
- Companies Mentioned: International Business Machines Corporation; AstraZeneca; Takeda Pharmaceutical Company Limited; IQVIA Holdings Inc.; BenevolentAI SA
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. AI-Based Clinical Trial Solution Providers Market Characteristics
3. AI-Based Clinical Trial Solution Providers Market Trends And Strategies
4. AI-Based Clinical Trial Solution Providers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global AI-Based Clinical Trial Solution Providers Growth Analysis And Strategic Analysis Framework
- 5.1. Global AI-Based Clinical Trial Solution Providers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global AI-Based Clinical Trial Solution Providers Market Growth Rate Analysis
- 5.4. Global AI-Based Clinical Trial Solution Providers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global AI-Based Clinical Trial Solution Providers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global AI-Based Clinical Trial Solution Providers Total Addressable Market (TAM)
6. AI-Based Clinical Trial Solution Providers Market Segmentation
- 6.1. Global AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Phase-I
- Phase-II
- Phase-III
- 6.2. Global AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oncology
- Cardiovascular Diseases
- Neurological Diseases Or Conditions
- Metabolic Diseases
- Infectious Diseases
- Other Therapeutic Applications
- 6.3. Global AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pharmaceutical Companies
- Academia
- Other End-Users
- 6.4. Global AI-Based Clinical Trial Solution Providers Market, Sub-Segmentation Of Phase-I, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Safety And Dosage Studies
- Early Pharmacokinetics Studies
- 6.5. Global AI-Based Clinical Trial Solution Providers Market, Sub-Segmentation Of Phase-Ii, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Efficacy Studies
- Dose-Response Studies
- 6.6. Global AI-Based Clinical Trial Solution Providers Market, Sub-Segmentation Of Phase-Iii, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Confirmatory Studies
- Comparative Effectiveness Research
7. AI-Based Clinical Trial Solution Providers Market Regional And Country Analysis
- 7.1. Global AI-Based Clinical Trial Solution Providers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global AI-Based Clinical Trial Solution Providers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific AI-Based Clinical Trial Solution Providers Market
- 8.1. Asia-Pacific AI-Based Clinical Trial Solution Providers Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China AI-Based Clinical Trial Solution Providers Market
- 9.1. China AI-Based Clinical Trial Solution Providers Market Overview
- 9.2. China AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India AI-Based Clinical Trial Solution Providers Market
- 10.1. India AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan AI-Based Clinical Trial Solution Providers Market
- 11.1. Japan AI-Based Clinical Trial Solution Providers Market Overview
- 11.2. Japan AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia AI-Based Clinical Trial Solution Providers Market
- 12.1. Australia AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia AI-Based Clinical Trial Solution Providers Market
- 13.1. Indonesia AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea AI-Based Clinical Trial Solution Providers Market
- 14.1. South Korea AI-Based Clinical Trial Solution Providers Market Overview
- 14.2. South Korea AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe AI-Based Clinical Trial Solution Providers Market
- 15.1. Western Europe AI-Based Clinical Trial Solution Providers Market Overview
- 15.2. Western Europe AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK AI-Based Clinical Trial Solution Providers Market
- 16.1. UK AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany AI-Based Clinical Trial Solution Providers Market
- 17.1. Germany AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France AI-Based Clinical Trial Solution Providers Market
- 18.1. France AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy AI-Based Clinical Trial Solution Providers Market
- 19.1. Italy AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain AI-Based Clinical Trial Solution Providers Market
- 20.1. Spain AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe AI-Based Clinical Trial Solution Providers Market
- 21.1. Eastern Europe AI-Based Clinical Trial Solution Providers Market Overview
- 21.2. Eastern Europe AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia AI-Based Clinical Trial Solution Providers Market
- 22.1. Russia AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America AI-Based Clinical Trial Solution Providers Market
- 23.1. North America AI-Based Clinical Trial Solution Providers Market Overview
- 23.2. North America AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA AI-Based Clinical Trial Solution Providers Market
- 24.1. USA AI-Based Clinical Trial Solution Providers Market Overview
- 24.2. USA AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada AI-Based Clinical Trial Solution Providers Market
- 25.1. Canada AI-Based Clinical Trial Solution Providers Market Overview
- 25.2. Canada AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America AI-Based Clinical Trial Solution Providers Market
- 26.1. South America AI-Based Clinical Trial Solution Providers Market Overview
- 26.2. South America AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil AI-Based Clinical Trial Solution Providers Market
- 27.1. Brazil AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East AI-Based Clinical Trial Solution Providers Market
- 28.1. Middle East AI-Based Clinical Trial Solution Providers Market Overview
- 28.2. Middle East AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa AI-Based Clinical Trial Solution Providers Market
- 29.1. Africa AI-Based Clinical Trial Solution Providers Market Overview
- 29.2. Africa AI-Based Clinical Trial Solution Providers Market, Segmentation By Clinical Trial Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa AI-Based Clinical Trial Solution Providers Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa AI-Based Clinical Trial Solution Providers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. AI-Based Clinical Trial Solution Providers Market Competitive Landscape And Company Profiles
- 30.1. AI-Based Clinical Trial Solution Providers Market Competitive Landscape
- 30.2. AI-Based Clinical Trial Solution Providers Market Company Profiles
- 30.2.1. International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AstraZeneca Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. BenevolentAI SA Overview, Products and Services, Strategy and Financial Analysis
31. AI-Based Clinical Trial Solution Providers Market Other Major And Innovative Companies
- 31.1. Charles River Laboratories
- 31.2. Flatiron Health
- 31.3. Saama Technologies Inc.
- 31.4. CytoReason
- 31.5. Median Technologies SAS
- 31.6. Concentro Health AI.
- 31.7. AiCure, LLC
- 31.8. DEEP LENS AI Inc.
- 31.9. GNS Healthcare, Inc.
- 31.10. Ardigen
- 31.11. Koneksa Health Inc.
- 31.12. Unlearn.AI Inc.
- 31.13. PathAI Inc.
- 31.14. Deep 6 AI Inc.
- 31.15. Intelligencia Inc.
32. Global AI-Based Clinical Trial Solution Providers Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The AI-Based Clinical Trial Solution Providers Market
34. Recent Developments In The AI-Based Clinical Trial Solution Providers Market
35. AI-Based Clinical Trial Solution Providers Market High Potential Countries, Segments and Strategies
- 35.1 AI-Based Clinical Trial Solution Providers Market In 2029 - Countries Offering Most New Opportunities
- 35.2 AI-Based Clinical Trial Solution Providers Market In 2029 - Segments Offering Most New Opportunities
- 35.3 AI-Based Clinical Trial Solution Providers Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
